These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33668712)

  • 21. Utilizing Pediatric Physiologically Based Pharmacokinetic Models to Examine Factors That Contribute to Methadone Pharmacokinetic Variability in Neonatal Abstinence Syndrome Patients.
    McPhail BT; Emoto C; Fukuda T; Butler D; Wiles JR; Akinbi H; Vinks AA
    J Clin Pharmacol; 2020 Apr; 60(4):453-465. PubMed ID: 31820437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ineffective morphine treatment regimen for the control of Neonatal Abstinence Syndrome in buprenorphine- and methadone-exposed infants.
    Gordon AL; Lopatko OV; Haslam RR; Stacey H; Pearson V; Woods A; Fisk A; White JM
    J Dev Orig Health Dis; 2012 Aug; 3(4):262-70. PubMed ID: 25102147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome.
    Gray TR; Choo RE; Concheiro M; Williams E; Elko A; Jansson LM; Jones HE; Huestis MA
    Addiction; 2010 Dec; 105(12):2151-9. PubMed ID: 20854338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transplacental methadone exposure and risk of Neonatal Opioid Withdrawal Syndrome.
    Bhatt-Mehta V; Jing X; Wang X; Zhu HJ
    Pharmacotherapy; 2024 Jan; 44(1):22-27. PubMed ID: 37574548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of neonatal abstinence syndrome in neonates born to opioid maintained women.
    Ebner N; Rohrmeister K; Winklbaur B; Baewert A; Jagsch R; Peternell A; Thau K; Fischer G
    Drug Alcohol Depend; 2007 Mar; 87(2-3):131-8. PubMed ID: 17000060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of a clinical pathway with methadone treatment protocol for treatment of neonatal abstinence syndrome following in utero drug exposure to substances of abuse*.
    Bhatt-Mehta V; Ng CM; Schumacher RE
    Pediatr Crit Care Med; 2014 Feb; 15(2):162-9. PubMed ID: 24141658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Buprenorphine pharmacotherapy for the management of neonatal abstinence syndrome in methadone-exposed neonates.
    Taleghani AA; Isemann BT; Rice WR; Ward LP; Wedig KE; Akinbi HT
    Paediatr Neonatal Pain; 2019 Dec; 1(2):33-38. PubMed ID: 35548374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antenatal methadone vs buprenorphine exposure and length of hospital stay in infants admitted to the intensive care unit with neonatal abstinence syndrome.
    Tolia VN; Murthy K; Bennett MM; Miller ES; Benjamin DK; Smith PB; Clark RH
    J Perinatol; 2018 Jan; 38(1):75-79. PubMed ID: 29048415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lidocaine (lignocaine) dosing regimen based upon a population pharmacokinetic model for preterm and term neonates with seizures.
    van den Broek MP; Huitema AD; van Hasselt JG; Groenendaal F; Toet MC; Egberts TC; de Vries LS; Rademaker CM
    Clin Pharmacokinet; 2011 Jul; 50(7):461-9. PubMed ID: 21651313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of naltrexone in treating opioid use disorder in pregnancy.
    Towers CV; Katz E; Weitz B; Visconti K
    Am J Obstet Gynecol; 2020 Jan; 222(1):83.e1-83.e8. PubMed ID: 31376396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methadone and perinatal outcomes: a prospective cohort study.
    Cleary BJ; Eogan M; O'Connell MP; Fahey T; Gallagher PJ; Clarke T; White MJ; McDermott C; O'Sullivan A; Carmody D; Gleeson J; Murphy DJ
    Addiction; 2012 Aug; 107(8):1482-92. PubMed ID: 22340442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are male neonates more vulnerable to neonatal abstinence syndrome than female neonates?
    Unger A; Jagsch R; Bäwert A; Winklbaur B; Rohrmeister K; Martin PR; Coyle M; Fischer G
    Gend Med; 2011 Dec; 8(6):355-64. PubMed ID: 22088886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway.
    Nechanská B; Mravčík V; Skurtveit S; Lund IO; Gabrhelík R; Engeland A; Handal M
    Addiction; 2018 Jul; 113(7):1286-1294. PubMed ID: 29443414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of neonatal outcomes in pregnant women undergoing medication-assisted treatment of opioid use disorder with methadone or buprenorphine/naloxone.
    Petrich M; Battin M; Walker E; Brown M; Abdelwahab M; Ma'ayeh M; Rood KM
    J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10481-10486. PubMed ID: 36202398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioid dependence and pregnancy: minimizing stress on the fetal brain.
    McCarthy JJ; Leamon MH; Finnegan LP; Fassbender C
    Am J Obstet Gynecol; 2017 Mar; 216(3):226-231. PubMed ID: 27729254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources.
    Dryden C; Young D; Hepburn M; Mactier H
    BJOG; 2009 Apr; 116(5):665-71. PubMed ID: 19220239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in hospital length of stay between neonates exposed to buprenorphine versus methadone in utero: A retrospective chart review.
    Fernandez S; Bruni T; Bishop L; Turuba R; Olibris B; Jumah NA
    Paediatr Child Health; 2019 May; 24(2):e104-e110. PubMed ID: 30996615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maternal vagal tone change in response to methadone is associated with neonatal abstinence syndrome severity in exposed neonates.
    Jansson LM; Dipietro JA; Elko A; Velez M
    J Matern Fetal Neonatal Med; 2007 Sep; 20(9):677-85. PubMed ID: 17701668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neonatal Abstinence Syndrome Severity Index Predicts 18-Month Neurodevelopmental Outcome in Neonates Randomized to Morphine or Methadone.
    Flannery T; Davis JM; Czynski AJ; Dansereau LM; Oliveira EL; Camardo SA; Lester BM
    J Pediatr; 2020 Dec; 227():101-107.e1. PubMed ID: 32805259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Buprenorphine and naloxone compared with methadone treatment in pregnancy.
    Wiegand SL; Stringer EM; Stuebe AM; Jones H; Seashore C; Thorp J
    Obstet Gynecol; 2015 Feb; 125(2):363-368. PubMed ID: 25569005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.